Select Medical Holdings (SEM) Depreciation & Amortization (CF) (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $37.7 million in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $37.7 million, up 8.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $143.2 million (down 22.46% YoY), and the FY2025 annual result was $140.3 million, down 31.19% from the prior year.
• Depreciation & Amortization (CF) advanced to $37.7 million in Q1 2026 per SEM's latest filing, from $36.2 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $54.1 million in Q1 2024 and troughed at $34.4 million in Q3 2025.
• A 5-year average of $46.8 million and a median of $51.0 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) slumped 35.62% in 2025, then advanced 8.21% in 2026.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $52.2 million in 2022, then gained by 3.33% to $54.0 million in 2023, then slipped by 15.27% to $45.7 million in 2024, then dropped by 20.85% to $36.2 million in 2025, then rose by 4.04% to $37.7 million in 2026.
• Business Quant data shows SEM's Depreciation & Amortization (CF) at $37.7 million in Q1 2026, $36.2 million in Q4 2025, and $34.4 million in Q3 2025.